復星醫藥AH股齊漲:A股逼近漲停,H股創歷史新高
格隆匯5月26日丨復星醫藥A股逼近漲停最高報70.5元,年內累漲近30%;H股亦漲近10%報65.9港元,創歷史新高價,年內累漲超70%。今日上午,台灣南投縣政府正式發文台流行疫情指揮中心,申請同意開放縣市政府購買上海復星代理的BNT疫苗。台灣南投縣長此前表示已與代理商上海復星醫藥接洽過,準備動用預備金購買30萬劑德國BNT疫苗。截至25日,台灣累計確診新冠肺炎病例超過5千人。


Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.